U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556900) titled 'Exploring the Potential of Artificial Intelligence for Earlier Breast Cancer Detection: A Retrospective Multi-Reader Study Based on AI-Assisted Mammographic Interpretation (EARLIEST-AI)' on April 17.
Brief Summary: EARLIEST-AI Study type: Two-phase, multi-reader, blinded retrospective observational study based on data from a single clinic.
The primary objective of the study is to assess the sensitivity and specificity of radiologists and Artificial Intelligence (AI) in interpreting mammographic examinations for breast cancer detection in a scenario where no previous examinations are available, and to compare the diagnostic perform...